CIK: 0001839209 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $365,623 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | 10,451,241 | $157,187 | 43.0% | $15.19 | 0.0% | COM | 88322Q108 |
| ARGX | ARGENX SE | 285,198 | $106,259 | 29.1% | $378.83 | — | SPONSORED ADR | 04016X101 |
| — | AMBRX BIOPHARMA INC | 11,304,573 | $100,837 | 27.6% | $4.46 | — | SPONSORED ADS | 02290A102 |
| KROS | KEROS THERAPEUTICS INC | 31,386 | $1,340 | 0.4% | $46.71 | +8.1% | COM | 492327101 |